Cargando…
Causes, Predictors, and Timing of Early Neurological Deterioration and Symptomatic Intracranial Hemorrhage After Administration of IV tPA
BACKGROUND: Acute ischemic stroke (AIS) is a major contributor toward healthcare-associated costs and services. Symptomatic intracranial hemorrhage (sICH) and early neurologic decline (END), defined as a National Health Institute Stroke Scale score decline of ≥ 4 within 24 h (with or without sICH),...
Autores principales: | Shah, Kavit, Clark, Alexander, Desai, Shashvat M., Jadhav, Ashutosh P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259538/ https://www.ncbi.nlm.nih.gov/pubmed/34228264 http://dx.doi.org/10.1007/s12028-021-01266-5 |
Ejemplares similares
-
Serum Creatinine May Indicate Risk of Symptomatic Intracranial Hemorrhage After Intravenous Tissue Plasminogen Activator (IV tPA)
por: Marsh, Elisabeth B., et al.
Publicado: (2013) -
Retrospective study of Heparin Administration for Ischemic Stroke when there is an IV-tPA Contraindication
por: Hakma, Zakaria, et al.
Publicado: (2014) -
Intracerebral hemorrhage after IV tPA for stroke as early symptom of ANCA-associated vasculitis
por: Esfahani, Neda Zarghami, et al.
Publicado: (2017) -
tPA or not tPA? Lysis therapy in the setting of COVID‐19 and ECMO
por: Cromartie, Anjelica, et al.
Publicado: (2022) -
Unintentional intramuscular administration of tPA/DNase for pleural infection
por: Popowicz, Natalia, et al.
Publicado: (2014)